A carregar...
Sodium-glucose Cotransporter 2 Inhibitors and Ketoacidosis – Clinical Implications in the Treatment of Patients with Type 2 Diabetes
The use of sodium-glucose cotransporter 2 inhibitors is associated with an increased risk of diabetic ketoacidosis. This risk has been reported in particular in off-label use of these agents in type 1 diabetes, but reports of risks in type 2 diabetes patients also exist. In type 2 diabetes ketoacido...
Na minha lista:
| Publicado no: | Eur Endocrinol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Touch Medical Media
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5813456/ https://ncbi.nlm.nih.gov/pubmed/29632585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17925/EE.2016.12.01.33 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|